Obermayer-Pietsch Barbara
Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Endocrinological-Nuclear-Medical Laboratory, Graz, Austria.
Wien Med Wochenschr. 2006 Mar;156(5-6):162-7. doi: 10.1007/s10354-005-0249-2.
Osteoporosis is a systemic skeletal disease comprising rarefaction of bone structure and loss of bone mass, finally leading to increased fracture risk. As a part of its multifactorial aetiology, twin and family studies have demonstrated an important genetic component of osteoporosis regarding many parameters of bone properties e. g. bone mineral density, with a heredity of 60-80 %. Whole genome screens, linkage analysis and candidate gene research have contributed to our current knowledge about genetic loci in osteoporosis. Genotyping of collagen alpha I, lactose intolerance or estrogen receptor alpha alleles are under investigation for their importance in individual and epidemiological practice, e. g. the European Union "GENOMOS" project with more than 50,000 subjects. In future, improved genotyping methods and design strategies as well as large scale epidemiological studies in the general population will bring the genetics of complex diseases such as osteoporosis to a point of success comparable to where mendelian genetics now firmly resides. Given the potential of these new techniques, a paradigm shift may occur both in diagnosis and prevention as well as in individualized treatment aspects of osteoporosis.
骨质疏松症是一种全身性骨骼疾病,其特征为骨结构稀疏和骨量丢失,最终导致骨折风险增加。作为其多因素病因的一部分,双胞胎和家族研究表明,就骨特性的许多参数(例如骨矿物质密度)而言,骨质疏松症具有重要的遗传成分,遗传率为60-80%。全基因组筛选、连锁分析和候选基因研究有助于我们目前对骨质疏松症基因位点的了解。胶原蛋白αI、乳糖不耐受或雌激素受体α等位基因的基因分型因其在个体和流行病学实践中的重要性而正在接受研究,例如欧盟的“GENOMOS”项目,该项目涉及超过50000名受试者。未来,改进的基因分型方法和设计策略以及普通人群中的大规模流行病学研究将使骨质疏松症等复杂疾病的遗传学取得与孟德尔遗传学目前所处的稳固地位相当的成功。鉴于这些新技术的潜力,骨质疏松症的诊断、预防以及个体化治疗方面可能会发生范式转变。